SCHEMBL8282666

SCHEMBL8282666

O=c1c(Br)c(N2CCOCC2)cnn1CCO

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.69
▸ NPC1 O15118 7/20 0.54
▸ RAB9A P51151 7/20 0.54
▸ MAPT P10636 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.41
▸ PKM P14618 1/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ LMNA P02545 2/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ TRPC5 Q9UL62 1/20 0.38
▸ MITF O75030 2/20 0.37
▸ HTT P42858 1/20 0.37
▸ BRD4 O60885 1/20 0.36
▸ BRD9 Q9H8M2 1/20 0.36
▸ CA12 O43570 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ S1PR4 O95977 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16035455 0.69 CNR1 (0.43) KMT2ANPC1RAB9AMAPTALDH1A1
SCHEMBL8283496 0.67 RAB9A (0.48) KMT2ANPC1RAB9AMAPTALDH1A1
SCHEMBL17227734 0.66 KMT2A (0.38) KMT2AALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL23573405 0.64 RAB9A (0.47) KMT2ANPC1RAB9APKMSMN1; SMN2
Emorfazone SCHEMBL26203 0.62 BRD4 (0.46) KMT2ANPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL2555460 0.62 BRD4 (0.46) KMT2ANPC1RAB9AALDH1A1PKM
SCHEMBL23573284 0.62 RAB9A (0.42) KMT2ANPC1RAB9APKMSMN1; SMN2
SCHEMBL23573483 0.62 MEN1 (0.33) KMT2ARAB9AMAPTALDH1A1
SCHEMBL5103228 0.61 ADORA2A (0.44) KMT2ANPC1RAB9AMAPTALDH1A1
SCHEMBL18412809 0.61 KMT2A (0.48) KMT2AMAPTALDH1A1PKMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005077915-A1 PYRIDAZINONES AS ANTAGONISTS OF A4 INTEGRINS JANSSEN PHARMACEUTICA, N.V. (BE) 2005-08-25 — — WO disclosed
Send feedback